Patent Docs: Supreme Court Decides Amgen v. Sanofi; Status Quo Extended
On Enablement - by Matt - On Drugs
November, 2022
Much is riding on how Supreme Court decides Amgen v. Sanofi
The 'Truth Leaks Out': Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments
Supreme Court Decides Amgen Inc. v. Sanofi, Publications, Insights
Amgen Inc. v. F. Hoffmann-LaRoche LTD Et Al - Document No. 937, PDF, Deposition (Law)
Patent Docs: Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir. 2014)
DePaul College of Law Academic Reputation by DePaulLaw - Issuu
Supreme Court Showdown: Amgen vs. Sanofi in a Battle for Antibody Rights, by Biotech Dilemma
Prakhyat Mathur on LinkedIn: Why I love working in labs with international diversity
Competition Law and Indian Pharmaceutical Industry
Top 5 healthcare moments of 2022 - News - MM+M
Patently Strategic: SCOTUS in Focus - Amgen v. Sanofi and the Future of Pharma Patents
Prakhyat Mathur on LinkedIn: Supreme Court rules invalid Amgen's patent on cholesterol-lowering drug